Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
23.02
-0.04 (-0.15%)
Jul 21, 2025, 2:07 PM - Market open

Vera Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover Vera Therapeutics stock have a consensus rating of "Buy" and an average price target of $64.63, which forecasts a 180.82% increase in the stock price over the next year. The lowest target is $26 and the highest is $100.

Price Target: $64.63 (+180.82%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$26$64.63$70$100
Change+12.97%+180.82%+204.15%+334.50%
* Price targets were last updated on Jun 2, 2025.

Analyst Ratings

The average analyst rating for Vera Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy222222
Buy555555
Hold111111
Sell000000
Strong Sell000000
Total888888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Scotiabank
Scotiabank
Buy
Maintains
$65$55
BuyMaintains$65$55+138.97%Jun 2, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$75$85
Strong BuyMaintains$75$85+269.32%Jun 2, 2025
Scotiabank
Scotiabank
Buy
Maintains
$60$55
BuyMaintains$60$55+138.97%May 12, 2025
Wedbush
Wedbush
Hold
Maintains
$34$26
HoldMaintains$34$26+12.97%May 7, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$107$100
BuyMaintains$107$100+334.50%May 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 881.07M
Revenue Next Year
n/a
EPS This Year
-3.34
from -2.75
EPS Next Year
-3.49
from -3.34
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028FY 2029
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028Dec 31, 2029
Revenue
-41.21M208.08M519.12M881.07M
Revenue Growth
--404.96%149.48%69.72%---
EPS
-166.93-2.43-3.35-2.25-2.75-3.34-3.49-2.38
EPS Growth
--------
Forward PE
--------
No. Analysts
-----151311
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/a85.8M461.6M
Avgn/a41.2M208.1M
Lown/a2.5M73.0M

Revenue Growth

Revenue Growth20252026202720282029
High--
1,020.1%
Avg--
405.0%
Low--
77.2%

EPS Forecast

EPS20252026202720282029
High-2.54-2.39-1.32
Avg-3.34-3.49-2.38
Low-3.86-4.54-3.62

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.